Skip to main content

OBSIDIAN CIO, LLC

Position in ENGN — enGene Therapeutics Inc.

CIK 1843581 NEW YORK, NY

Position in ENGN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$25,950
New position
Shares Held
15,000
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#50
of 60 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 0% Shared 0% None 100%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OBSIDIAN CIO, LLC holds $122,801 across 2 Biotechnology names. ENGN ranks #2 (21.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ENGN
enGene Therapeutics Inc.
This page
15,000 $25,950

All Filings in ENGN

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $25,950 15,000